Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
07/2012
07/10/2012CA2462930C Remodeling and glycoconjugation of peptides
07/10/2012CA2446951C Polythiourea lipid derivatives
07/10/2012CA2442053C Composition comprising a prebiotic for decreasing inflammatory process and abnormal activation of non-specific immune parameters
07/10/2012CA2417311C Crystalline alkali metal salts of lansoprazole and their production and use
07/10/2012CA2400916C Aminoadamantane derivatives as therapeutic agents
07/05/2012WO2012092594A2 Preparations for topical prevention and/or treatment of oral allergic symptoms due to oral contact with fruits and/or vegetables
07/05/2012WO2012092305A2 Nanonized iron compositions and methods of use thereof
07/05/2012WO2012092160A2 Human milk oligosaccharides to promote growth of beneficial bacteria
07/05/2012WO2012092157A2 Nutritional formulations including human milk oligosaccharides and antioxidants and uses thereof
07/05/2012WO2012092155A1 Synbiotic combination of probiotic and human milk oligosaccharides to promote growth of beneficial microbiota
07/05/2012WO2012092153A1 Nutritional compositions comprising human milk oligosaccharides and nucleotides and uses thereof for treating and/or preventing enteric viral infection
07/05/2012WO2012092103A1 Gemcabene and derivatives for treating pancreatitis
07/05/2012WO2012092090A1 Nutritional products including a fat system including free fatty acids
07/05/2012WO2012092088A1 Nutritional products including a novel fat system including monoglycerides
07/05/2012WO2012092087A1 Methods for decreasing the incidence of necrotizing enterocolitis, colic, and short bowel syndrome in an infant, toddler, or child
07/05/2012WO2012092086A1 Methods for improving tolerance, digestion, and lipid soluble nutrient absorption in an infant, toddler, or child
07/05/2012WO2012091598A1 Composition for eliminating toxins from the body and for normalizing the microflora in the intestines
07/05/2012WO2012091492A2 Herbal extract, pharmaceutical composition including the same and health functional food including the same
07/05/2012WO2012091440A2 Composition for improvement, treatment and prevention of gastrointestinal motility disorders
07/05/2012WO2012091357A2 Composition for prevention of nausea or vomiting
07/05/2012WO2012089808A1 New allium porrum l. extract with powerful cicatrizant, anti-inflammatory and anti-microbic activity, for cutaneous lesion treating and its preparation method
07/05/2012WO2012089784A1 Fiber and probiotics for reducing intestinal symptoms related to chronic stress
07/05/2012WO2012089783A1 A nutritional composition comprising fiber and probiotics for reducing stress-related intestinal symptoms
07/05/2012WO2012089782A1 Fiber and probiotics for reducing intestinal symptoms related to stress
07/05/2012WO2012089738A1 A combination of an opioid agonist and an opioid antagonist in the treatment of parkinson's disease
07/05/2012WO2012089175A2 Traditional chinese medicinal tea made by microbial fermentation
07/05/2012WO2012088885A1 Total flavonoid extract of fructus aurantii immaturus or fructus aurantii, and use thereof
07/05/2012WO2012088794A1 Herbal tea without excipient used as milk supplement and method of preparing the same
07/05/2012WO2012088763A1 Hepatitis a virus strain sh and method for adapting same to diploid cells
07/05/2012WO2012040707A3 Materials and methods for improving gastrointestinal function
07/05/2012US20120172449 Polyamine transport inhibitors as novel therapeutics
07/05/2012US20120172445 Nutritional products including a novel fat system including fatty acids
07/05/2012US20120172443 Nutritional products including a novel fat system including monoglycerides
07/05/2012US20120172442 Methods for decreasing the incidence of necrotizing enterocolitis, colic, and short bowel syndrome in an infant, toddler, or child
07/05/2012US20120172438 Glycyrrhetinic acid ester derivative synthesis method and deoxoglycyrrhetinic acid ester compound
07/05/2012US20120172436 Liver Regeneration Accelerator Comprising Betaine
07/05/2012US20120172434 Methods for improving tolerance, digestion, and lipid soluble nutrient absorption in an infant, toddler, or child
07/05/2012US20120172429 Permanently charged sodium and calcium channel blockers as anti- inflammatory agents
07/05/2012US20120172397 HEXAHYDROCYCLOPENTA[f]INDAZOLE 5-YL ETHANOLS AND DERIVATIVES THEREOF AS SELECTIVE GLUCOCORTICOID RECEPTOR MODULATORS
07/05/2012US20120172396 2-adamantylurea derivatives as selective 11b-hsd1 inhibitors
07/05/2012US20120172393 (4-Phenyl-piperidin-1-yl)-[5-(1H-pyrazol-4-yl)-thiophen-3-yl]-methanone Compounds and Their Use
07/05/2012US20120172389 Treatment of fibrosing disorders
07/05/2012US20120172382 Pyridone amides and analogs exhibiting anti-cancer and anti-proliferative activities
07/05/2012US20120172379 4 substituted pyrazolopyrimidines
07/05/2012US20120172359 Oxazine Derivatives and their Use in the Treatment of Neurological Disorders
07/05/2012US20120172353 1,4-diaza-bicyclo[3.2.2]nonyl oxadiazolyl compounds and their medical use
07/05/2012US20120172352 Pyrazoline dione derivatives as nadph oxidase inhibitors
07/05/2012US20120172350 Histamine h3 inverse agonists and antagonists and methods of use thereof
07/05/2012US20120172337 Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses
07/05/2012US20120172335 Substituted benzimidazolone derivatives, medicaments comprising them and their use
07/05/2012US20120172325 Methods and Compositions for the Treatment of Gastrointestinal Disorders
07/05/2012US20120172324 Compositions and methods for reducing the risk of agent-induced liver toxicity
07/05/2012US20120172319 Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers, or children using human milk oligosaccharides
07/05/2012US20120172294 Treatment of diseases
07/05/2012US20120172285 Methods and compositions for specific modulation of mcl-1
07/05/2012US20120172283 Methods and compositions for targeted drug delivery
07/05/2012US20120171312 Therapy of non alcoholic fatty liver disease utilizing inula viscosa extract
07/05/2012US20120171284 Celecoxib compositions
07/05/2012US20120171253 Fibromodulin Peptide
07/05/2012US20120171234 Novel Biologically Active Peptides and their New Uses
07/05/2012US20120171233 Peptide inhibitors for mediating stress responses
07/05/2012US20120171221 Biomarkers for the early detection of autoimmune diseases
07/05/2012US20120171208 Anti-PRO87299 Antibodies
07/05/2012US20120171206 Methods of stimulating liver regeneration
07/05/2012US20120171202 Rage Fusion Proteins And Methods Of Use
07/05/2012US20120171199 Tricyclic pi3k inhibitor compounds and methods of use
07/05/2012US20120171197 Binding members for interleukin-4 receptor alpha (IL-4Ra) - 173
07/05/2012US20120171190 Methods for diagnosing chronic diarrhea through protein secretion analysis
07/05/2012US20120171186 method for producing a nutraceutical composition and the nutraceutical produced by the method
07/05/2012US20120171180 Compositions comprising amnion derived adherent cells and platelet-rich plasma
07/05/2012US20120171176 Use of nutritional compositions including lactoferrin and one or more prebiotics in inhibiting adhesion of pathogens in the gastrointestinal tract
07/05/2012US20120171170 Treatment of collagen gene related diseases by inhibition of natural antisense transcript to a collagen gene
07/05/2012US20120171168 Method for treating pancreatitis with mesenchymal stem cells
07/05/2012US20120171166 Synbiotic combination of probiotic and human milk oligosaccharides to promote growth of beneficial microbiota
07/05/2012US20120171165 Human milk oligosaccharides to promote growth of beneficial bacteria
07/05/2012US20120171162 Fermented food products containing probiotic strains, and method for preparing same
07/05/2012US20120171161 Compositions comprising placental stem cells and platelet rich plasma, and methods of use thereof
07/05/2012US20120171126 NOVEL [3,2-c] HETEROARYL STEROIDS AS GLUCOCORTICOID RECEPTOR AGONISTS COMPOSITIONS AND USES THEREOF
07/05/2012US20120171116 Arginase Inhibitors and Methods of Use Thereof
07/05/2012DE102011000020A1 Wirkstoff, der Indocyaningrün und/oder Infracyaningrün enthält Contains active substance, the indocyanine green and / or Infracyaningrün
07/05/2012CA2822921A1 Method for treating pancreatitis
07/05/2012CA2822664A1 Nutritional formulations including human milk oligosaccharides and antioxidants and uses thereof
07/05/2012CA2822660A1 Synbiotic combination of probiotic and human milk oligosaccharides to promote growth of beneficial microbiota
07/05/2012CA2822528A1 A combination of an opioid agonist and an opioid antagonist in the treatment of parkinson's disease
07/05/2012CA2822500A1 Human milk oligosaccharides to promote growth of beneficial bacteria
07/05/2012CA2822490A1 Nutritional compositions comprising human milk oligosaccharides and nucleotides and uses thereof for treating and/or preventing enteric viral infection
07/05/2012CA2821935A1 Methods for decreasing the incidence of necrotizing enterocolitis, colic, and short bowel syndrome in an infant, toddler, or child
07/05/2012CA2821770A1 Methods for improving tolerance, digestion, and lipid soluble nutrient absorption in an infant, toddler, or child
07/05/2012CA2820965A1 Nutritional products including a fat system including free fatty acids
07/05/2012CA2820960A1 Nutritional products including a novel fat system including monoglycerides
07/04/2012EP2471792A1 3-(biaryloxy) propionic acid derivative
07/04/2012EP2471777A1 Novel tetrahydroisoquinoline compounds
07/04/2012EP2471542A1 Therapeutic agent for liver-related diseases
07/04/2012EP2471533A1 Aryl carbonyl derivatives as therapeutic agents
07/04/2012EP2471388A1 Paediatric fibre mixture
07/04/2012EP2470553A1 Polyhydroxylated bile acids for treatment of biliary disorders
07/04/2012EP2470188A1 Bifidobacterium longum and functional gi disorders
07/04/2012EP1817036B1 Modulators of muscarinic receptors
07/04/2012EP1487805B1 Pyrimidine derivatives
07/04/2012EP1461047B1 Compositions and methods for animal treatment
1 ... 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 ... 1258